CH de Bicêtre; Pediatrie Generale

Le Kremlin-Bicêtre 94275

0 studies enrolling now · 3 studies all time

What they study most

Juvenile Idiopathic Arthritis

Studies at this site

• Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis — Completed
• A Study of Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis — Completed
• A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis — Completed